Cuu Long Pharmaceutical JSCHOSE: DCL

DCL: the explanation of changes in profit Q3-2025

· Issued by Cuu Long Pharmaceutical JSC

Filed with HOSE ·

Cuu Long Pharmaceutical Jsc (DCL)

THE EXPLANATION OF CHANGES IN PROFIT Q3-2025 of Cuu Long Pharmaceutical Joint Stock Company as follows: 

View Attachment

6ix hasn’t read this filing yet.

Cuu Long Pharmaceutical JSC on 6ix

Later from Cuu Long Pharmaceutical JSC

All Cuu Long Pharmaceutical JSC news releases